On September 9, 2026, the Wall Street Journal reported that Apple Inc. (NASDAQ:AAPL) is undertaking a major overhaul of its Health app and Apple Watch strategy. It debuts the Apple Watch Series 12 and Ultra 4 with an upgraded Health Sensing System alongside an Apple Intelligence-driven software redesign coming to iOS 27 that introduces a daily “readiness score” synthesizing activity, sleep, and vitals into a single 0-to-10 rating with plain-language guidance.
The overhaul comes as competitors including Whoop, Oura, and Google’s $100 Fitbit Air have built substantial businesses around simpler, screenless wearables focused on recovery and passive health monitoring. It draws consumers away from Apple’s more cluttered, screen-based approach.
Don’t Miss: Apple (AAPL)’s New Mac Mini and Studio Bet Big on On-Device AI
Bull Case
Apple Inc. (NASDAQ:AAPL) is directly addressing one of the clearest weaknesses in its health ecosystem. The Health app has long overwhelmed users with data while offering too little guidance. It creates an opening for rivals such as Oura and Whoop. Apple’s redesigned app uses Apple Intelligence to surface personalized insights throughout the day. It could make the company’s health platform more useful and solidify engagement across the iPhone and Apple Watch ecosystem.
Apple is pairing the software overhaul with new Watch hardware that could strengthen the upgrade case for existing users. Apple Watch Series 12 and Ultra 4 introduce a redesigned health-sensing system, more frequent heart-rate measurements, and a new readiness score that classifies users as “Recover,” “Pace Yourself,” “Ready,” or “Go for it.” By linking new sensors with clearer health guidance, Apple can give users a more tangible reason to upgrade while making the Watch more competitive with recovery-focused wearables.
The redesigned Health app draws out Apple’s health platform beyond basic activity tracking and could deepen ecosystem loyalty. Apple is adding personalized insights, long-term health analysis, at-home physical assessments, lab testing through Quest Diagnostics, and new longevity features such as Health Age. These additions make the Health app more useful as an ongoing health-management platform rather than simply a repository for biometric data. It potentially increases the value users receive from staying inside Apple’s hardware and software ecosystem.
Look Into: Medtronic (MDT) Raises its Outlook Again as Heart Device Demand Keeps Climbing
Bear Case
Apple Inc. (NASDAQ:AAPL) faces much stronger competition from screenless health wearables than it did when the Apple Watch first established its leadership. Oura reported a 74% increase in revenue to $1.21 billion for the nine months through June and earned $60.8 million as it filed for a U.S. IPO. It shows that demand for dedicated health-tracking devices has become commercially significant. Sales of screenless, subscription-based wearables such as Oura and Whoop are surging. So Apple now needs to win back users who value passive tracking and simpler guidance over a traditional smartwatch experience.
Apple’s health strategy has gone through real leadership and product changes, which raises execution risk around the broader overhaul. Services chief Eddy Cue took over Apple’s health organization after longtime executive Jeff Williams retired. Apple scaled back its planned AI health-coaching service, code-named Mulberry, after management decided the original concept did not compete strongly enough with products from Oura and Whoop. Now, Apple plans to distribute some of those features through the Health app instead. It shows that the firm has already had to rethink a major part of its health strategy.
The initial rollout limits how quickly Apple can turn the redesigned Health app into a global competitive advantage. Apple plans to launch the new Health experience first in U.S. English, with additional languages coming later, while some of the most important features require newer hardware such as the Apple Watch Series 12 or Ultra 4. That approach could slow use among Apple’s large international user base and existing Watch owners who do not plan to upgrade immediately.
Hedge Fund Sentiment
Apple Inc. (NASDAQ:AAPL)’s hedge fund count was little changed at 169 funds in the second quarter versus 170 in the first, with position value rising to $124.80 billion from $107.48 billion, according to Insider Monkey’s database. Alphabet, whose Fitbit unit competes directly in the wearables category Apple is trying to defend, saw stronger growth, with holders climbing to 275 from 265 and position value jumping to $93.74 billion from $72.41 billion.
Conclusion
Apple’s Health app overhaul addresses a real weakness in an otherwise powerful wearables ecosystem by turning raw biometric data into clearer, more personalized guidance. New Watch sensors, readiness scores, AI-powered insights and broader health-management tools could strengthen user engagement and create another reason for consumers to remain inside Apple’s ecosystem.
But Oura and Whoop have already shown strong demand for simpler, screenless health tracking. Apple has had to rethink parts of its own AI health strategy and will initially limit the redesign by language and hardware availability. Investors should now look at whether Apple can use its scale and integrated hardware-software model to close the usability gap with specialized wearables and turn health into a stronger driver of device upgrades and ecosystem retention.
Read Next: Meta (META) Hands its New AI Agent the Keys to Your Inbox and Wallet and Baldness Drug Stocks like Veradermics (MANE) and Absci (ABSI) Are Chasing the Same Wall Street Magic as Ozempic
